PATENT CLAIM ANALYSIS

Application Number: 15742996
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "102000"]

Abstract:
The invention relates to the use of phytate or any of the salts thereof for preventing the formation of advanced glycation end-products (AGE), toxic products that are produced in pathologies such as diabetes, either alone or combined with B6 vitamins such as pyridoxamine and forming part of a medicament or a pharmaceutical composition produced so as to be administered via oral, rectal, subcutaneous, intra-arterial, intramuscular, intraspinal, intracranial, intravenous or inhalation routes.

Claim (Index 9):
A composition that comprises phytic acid or any of the salts thereof and at least one derivative of vitamin B6 or any of the salts thereof, with the composition being prepared so as to be administered via oral, rectal, subcutaneous, intra-arterial, intramuscular, interspinal, intracranial, intravenous, or inhalation routes.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 86.0
- Lexical Diversity: 1.36066
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14202161', '11320834', '11218226', '10573973', '11923000']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7418116634401865
- 35 USC 102 Novelty (BERT): 0.4710041745335097
- Combined Prediction Score: 0.7147309145495189
- Mean Citation Score: 130.262096
- Max Citation Score: 146.89313
- Similarity Product: 108.62736253756702

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test